Recombinant Human POLE Protein，GST

POLE (DNA polymerase epsilon) is a crucial enzyme involved in DNA replication and repair, playing a significant role in maintaining the integrity of the genome. Research on POLE has gained momentum due to its association with various neoplastic conditions, particularly certain types of cancers. Mutations in the POLE gene have been identified as a common occurrence in diverse tumors, including endometrial and colorectal cancers. These mutations often lead to an elevated error rate during DNA replication, resulting in hypermutation phenotypes, which can influence tumorigenesis and affect patient prognosis. Understanding the functional implications of POLE mutations is essential not only for elucidating the mechanisms underlying cancer development but also for improving therapeutic strategies. The identification of POLE as a contributor to the hypermutated phenotype has opened new avenues for immunotherapy and targeted treatment approaches, particularly in cancers characterized by high mutation burdens. Researchers are investigating the role of POLE in DNA damage response and its potential interactions with other cellular pathways, aiming to uncover the broader implications of POLE dysfunction in human health. Furthermore, the development of advanced genomic techniques has enabled more comprehensive characterization of POLE-related mutations, facilitating the exploration of their clinical relevance and potential as biomarkers for cancer diagnosis and prognosis. Thus, ongoing studies on POLE and its mutational landscape are imperative for advancing our understanding of cancer biology and enhancing precision medicine strategies.